News Conference News EuroPCR 2025 ‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI Michael O'Riordan May 29, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Conference News SCAI 2025 When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer L.A. McKeown May 09, 2025
News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Conference News ACC 2025 RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI Michael O'Riordan April 02, 2025
News Daily News The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis Yael L. Maxwell March 24, 2025
News Daily News Cannabis Use Again Tied to Increased CVD Risk in Young People L.A. McKeown March 19, 2025
News Daily News Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA Michael O'Riordan February 24, 2025
News Daily News High Survival Rates Seen in Sports-Related Cardiac Arrest in Canada Michael O'Riordan February 10, 2025
News Daily News Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab Michael O'Riordan February 05, 2025
News Daily News DRIVE-STEMI Supports Less Restrictive Driving Guidance After Acute MI L.A. McKeown January 23, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many L.A. McKeown January 16, 2025